Crystalline forms of 3-substituted 1,2,4-oxadiazole
US-11136300-B2 · Oct 5, 2021 · US
1,2,4-oxadiazole derivatives as immunomodulators
US11512060B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11512060-B2 |
| Application number | US-202117192279-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2021 |
| Priority date | Sep 6, 2013 |
| Publication date | Nov 29, 2022 |
| Grant date | Nov 29, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to pharmaceutical compositions of 1,2,4-oxadiazole compounds or a pharmaceutically acceptable salt thereof of formula (I) In the formula Q is O, R 1 is the side chain of Ser, R 2 is —CO-Thr, R 3 is the side chain of Asn or Glu, and R 4 , R 5 and R 6 are each H.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising a compound and a pharmaceutically acceptable excipient, wherein the compound is or a pharmaceutically acceptable salt thereof. 2. The pharmaceutical composition of claim 1 , wherein the compound is 3. The pharmaceutical composition of claim 1 , wherein the compound is a pharmaceutically acceptable salt of 4. The pharmaceutical composition of claim 1 , wherein the compound is 5. The pharmaceutical composition of claim 1 , wherein the compound is a pharmaceutically acceptable salt of
Assignees
Inventors
Classifications
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
having two nitrogen atoms and more than one oxygen atom · CPC title
Drugs for disorders of the endocrine system · CPC title
Drugs for skeletal disorders · CPC title
for herpes viruses · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11512060B2 cover?
- The present invention relates to pharmaceutical compositions of 1,2,4-oxadiazole compounds or a pharmaceutically acceptable salt thereof of formula (I) In the formula Q is O, R 1 is the side chain of Ser, R 2 is —CO-Thr, R 3 is the side chain of Asn or Glu, and R 4 , R 5 and R 6 are each H.
- Who is the assignee on this patent?
- Sasikumar Pottayil Govindan Nair, Ramachandra Muralidhara, Naremaddepalli Seetharamaiah Setty Sudarshan, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/4245. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).